ClinicalTrials.gg
CompletedNCT07158632Updated May 8, 2026

Effects of Multiple Interventions on Under-Five Diarrhea

An interventional study of handwashing education and water chlorination in Diarrheal Diseases, sponsored by Jimma University. Completed at 1 site in Ethiopia. Open to participants aged 6 Months to 59 Months. Per ClinicalTrials.gov, last updated 2026-05-08.

Sponsored by Jimma University · Not applicable, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
835
Allocation
Randomized
Ages
6 Months to 59 Months
Sex
All
01

Study summary

Diarrhea is the leading cause of death, especially in developed nations. Though there are effective interventions, diarrhea remains the leading cause of death among children in Ethiopia

Read the detailed description

Diarrheal disease is the major cause of child morbidity and mortality in low-income countries, including Ethiopia. Diarrhea is more common in areas with a lack of water sanitation and hygiene. Even though there are available effective interventions, diarrhea remains the major cause of child morbidity and mortality in Ethiopia. Therefore, the aim of this study is to give up-to-date information on multiple interventions that reduce diarrheal disease.

02

Conditions studied

  • Diarrheal Diseases

Browse trials for

Keywords

  • central Ethiopia, Diarrhea, Ethiopia, Multiple Interventions
03

In context

Diarrhea

880 studies on the registry are indexed under Diarrhea; 78 are open to participants now.

This study's enrollment of 835 is above the median of 137 across 740 interventional studies indexed under Diarrhea.

Browse Diarrhea studies →

Lead sponsor

Jimma University is the lead sponsor of 28 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Months to 59 Months
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria

  • a child age from 6 to 59 months Exclusion Criteria
  • child with persistent diarrhea, severely ill mother, households that receive treated water
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
835 participants (actual)

Study arms

  • Experimental
    handwashing education only arm

    Arm A: This arm receives handwashing education.

    Behavioral: handwashing education

  • Experimental
    water chlorination only arm

    Arm B: This arm receives household water chlorination

    Behavioral: water chlorination

  • Experimental
    combined hand washing and water chlorination arm

    Arm C: This arm receives both handwashing education and water chlorination.

    Behavioral: combined intervention

  • No intervention
    No intervention arm

    This arm have not receive any intervention

Interventions

  • Behavioralhandwashing education

    Arm A: This arm receive handwashing education using social and behavioral change communication

  • Behavioralwater chlorination

    Arm B: This arm receives water chlorination intervention

  • Behavioralcombined intervention

    Arm C: This arm receives combined handwashing and water chlorination intervention

06

What researchers measure

Primary outcomes

  1. Incidence of diarrhea among under-five children

    Time frame: At baseline and to four-month follow-up

Secondary outcomes

  1. Adherence of interventions

    percentage of soap availability near toilet and residual chlorine in drinking water

    Time frame: Up to four-month follow-up

07

Study locations

1 site
  • Butajira Health Center
    Butajīra, Ethiopia
08

References and documents

Publications

  • Breastfeeding and protection against diarrhea: an integrative review of literature Aleitamento materno e proteção contra diarreia: revisão integrativa da literatura Floriacy Stabnow Santos1 , Felipe César Stabnow Santos2 Adriana Moraes Leite1 , Leonardo Hunaldo dos Santos3 , Débora Falleiros de Mello1

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2025 to primary completion in Feb 2026, 5 months.

Of 129 non-industry interventional studies with no phase under Diarrhea, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 36. This study's 5 months is below that.

Counting every sponsor, half of 164 studies reached it within 14 months; a quarter within 5 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 22, 2025
First posted
Sep 8, 2025
StartActual
Sep 11, 2025
Primary completionActual
Feb 12, 2026
CompletionActual
Feb 19, 2026
Last update
May 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07158632
Lead sponsor
Jimma University
Responsible party
Melaku Tesfaye (PhD Candidate, Jimma University) — Principal investigator
First posted
Sep 8, 2025
Start date
Sep 11, 2025
Primary completion
Feb 12, 2026
Completion
Feb 19, 2026
Last update
May 8, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion